PATENT CLAIM ANALYSIS

Application Number: 16052948
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "172100"]

Abstract:
Provided herein are methods and compositions for treating and/or reducing the risk of developing a condition associated with fibrosis and/or collagen deposition in a subject. In one embodiment, the method comprises administering an effective amount of an IRE1α inhibitor to the subject; wherein the subject is identified as having a risk of developing and/or a need for treatment of the condition associated with fibrosis and/or collagen deposition.

Claim (Index 13):
The method of  claim 1 , wherein the IRE1\u03b1 inhibitor is an antibody specific to IRE1\u03b1.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 96.0
- Lexical Diversity: 1.57778
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10779069', '15747697', '15265813', '14896168', '15625399']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6797241904962033
- 35 USC 102 Novelty (BERT): 0.514245990933113
- Combined Prediction Score: 0.6631763705398943
- Mean Citation Score: 232.838284
- Max Citation Score: 244.84311
- Similarity Product: 158.50431292325374

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test